Silverman Marni N, Miller Andrew H, Biron Christine A, Pearce Brad D
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Endocrinology. 2004 Aug;145(8):3580-9. doi: 10.1210/en.2003-1421. Epub 2004 Mar 24.
There has been longstanding interest in the capacity of the immune system to access immunomodulatory glucocorticoid responses without invoking upstream neuroendocrine secretagogues, including CRH and ACTH. Here, we investigate the role of CRH and ACTH in adrenal glucocorticoid responses to murine cytomegalovirus (MCMV). Mice infected with MCMV exhibit IL-6-dependent glucocorticoid responses that peak at 36 h post infection and protect against cytokine (TNFalpha)-mediated lethality. Acute administration of a CRH-antibody (Ab) completely eliminated ACTH responses to both low- and high-dose MCMV. However, corticosterone responses in CRH-Ab-treated animals remained apparent in mice infected with low-dose MCMV and were robust in mice infected with high-dose MCMV. CRH-knockout (KO) mice exhibited robust corticosterone responses to both MCMV doses, despite reduced baseline and MCMV-induced ACTH. Interestingly, robust corticosterone responses in CRH-Ab-treated and CRH-KO mice were associated with exaggerated IL-6 levels, and IL-6 and corticosterone concentrations in infected CRH-Ab-treated animals were significantly correlated. Neutralization of IL-6 responses in infected CRH-KO mice reduced corticosterone responses by approximately 70%. Finally, MCMV-infected mice deprived of ACTH by hypophysectomy failed to elicit glucocorticoid responses, despite elevated plasma IL-6 concentrations. Taken together, these results suggest that a greater than normal induction of IL-6 compensates for the absence of a normal CRH-dependent ACTH surge during viral infection. This enhanced IL-6 response, in turn, may mediate a direct immune-adrenal pathway that can become a predominant driving force for glucocorticoid induction in the absence of CRH. However, the presence of ACTH appears to serve as a necessary permissive factor, enabling direct cytokine actions on the adrenal gland.
长期以来,人们一直关注免疫系统在不调用包括促肾上腺皮质激素释放激素(CRH)和促肾上腺皮质激素(ACTH)在内的上游神经内分泌促分泌素的情况下产生免疫调节性糖皮质激素反应的能力。在此,我们研究了CRH和ACTH在肾上腺对鼠巨细胞病毒(MCMV)的糖皮质激素反应中的作用。感染MCMV的小鼠表现出依赖白细胞介素-6(IL-6)的糖皮质激素反应,在感染后36小时达到峰值,并能抵御细胞因子(肿瘤坏死因子α)介导的致死性。急性给予CRH抗体(Ab)可完全消除对低剂量和高剂量MCMV的ACTH反应。然而,在感染低剂量MCMV的小鼠中,经CRH-Ab处理的动物的皮质酮反应仍然明显,而在感染高剂量MCMV的小鼠中则很强劲。CRH基因敲除(KO)小鼠对两种MCMV剂量均表现出强劲的皮质酮反应,尽管基线和MCMV诱导的ACTH有所降低。有趣的是,经CRH-Ab处理的小鼠和CRH-KO小鼠中强劲的皮质酮反应与IL-6水平升高有关,并且在感染的经CRH-Ab处理的动物中,IL-6和皮质酮浓度显著相关。在感染的CRH-KO小鼠中中和IL-6反应可使皮质酮反应降低约70%。最后,垂体切除术后缺乏ACTH的MCMV感染小鼠尽管血浆IL-6浓度升高,但未能引发糖皮质激素反应。综上所述,这些结果表明,IL-6的诱导高于正常水平可补偿病毒感染期间正常的CRH依赖性ACTH激增的缺失。这种增强的IL-6反应反过来可能介导一条直接的免疫-肾上腺途径,在没有CRH的情况下,该途径可能成为糖皮质激素诱导的主要驱动力。然而,ACTH的存在似乎是一个必要的允许因素,使细胞因子能够直接作用于肾上腺。